Boxer Amir Khan has been banned for two years after the use of a prohibited substance.
On 19 February 2022, UK Anti-Doping (UKAD) collected an In-Competition urine Sample from Khan after his fight against Kell Brook at the Manchester Arena. His Sample returned an Adverse Analytical Finding (AAF) for ostarine.
Ostarine is a selective androgen receptor modulator (SARM). The substance is listed on the World Anti-Doping Agency’s (WADA) 2022 Prohibited List as an anabolic agent and is prohibited in sport at all times.
Khan accepted the violations charged but maintained that his ingestion of ostarine was not ‘intentional. As a consequence his case was referred to the National Anti-Doping Panel to be considered by an independent tribunal.
Khan’s two-year ban is deemed to have commenced on 6th April 2022 (the date his Provisional Suspension was imposed) and will expire on 5th April 2024.
Read More Like this
Speaking on the case, UKAD Chief Executive Jane Rumble said, “This case serves as a reminder that UKAD will diligently pursue Anti-Doping Rule Violations in order to protect clean sport.”
“Strict liability means Athletes are ultimately responsible for what they ingest and for the presence of any Prohibited Substances in a Sample. It is important that all Athletes and their support personnel, whatever level they are competing at, take their anti-doping responsibilities seriously. Not doing so risks damaging not only an Athlete’s career, but also undermining public confidence in clean sport.”
Incidentally, Khan had announced his retirement from boxing in May 2022.
